Impact of reimbursement program on liver‐related mortality in patients with chronic hepatitis B in Beijing, China-Reference-Cited by-同舟云学术

Impact of reimbursement program on liver‐related mortality in patients with chronic hepatitis B in Beijing, China

Published:2019-07-21 Issue:9 Volume:20 Page:467-475
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J Dig Dis

Author:

Li Min¹^ORCID,Kong Yuan Yuan¹^ORCID,Wu Shan Shan¹,Zhou Jia Ling²,Wu Xiao Ning²,Wang Lin²,Su Jian Ting³,Ou Xiao Juan²,You Hong²,Xie Xue Qin⁴,Wei Zai Hua³,Jia Ji Dong²^ORCID

Affiliation:

1. Clinical Epidemiology and Evidence‐Based Medicine Unit, National Clinical Research Center for Digestive Diseases, Beijing Friendship HospitalCapital Medical University Beijing China

2. Liver Research Center, Beijing Friendship HospitalCapital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis; National Clinical Research Center for Digestive Diseases Beijing China

3. Statistics CenterBeijing Center for Diseases Prevention and Control Beijing China

4. Statistics CenterNational Health and Family Planning Commission of the People's Republic of China Beijing China

Funder

Beijing Municipal Science and Technology Commission

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.12794

Reference23 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. WHO.Global Hepatitis Report 2017. https://apps.who.int/iris/bitstream/handle/10665/255016/9789241565455‐eng.pdf;jsessionid=9FE958F6DB9D49C8A682C1EA00CFCE34?sequence=1. Accessed June 26 2019.

3. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity

4. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

5. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of hepatitis B virus treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort study;The Lancet Regional Health - Americas;2024-08

2. Comprehensive approach to controlling chronic hepatitis B in China;Clinical and Molecular Hepatology;2024-04-01

3. Effect of HBV Treatment on All-Cause and Liver-Related Death Among Individuals with HBV and Cirrhosis in British Columbia;2023

4. Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China;Journal of Clinical and Translational Hepatology;2022-06-21

5. Uptake of hepatitis B antiviral treatment: A panel data analysis of 31 provinces in China (2013–2020);Liver International;2022-06-16